Study of E7389 Liposomal Formulation in Participants With Solid Tumor
Study of E7389 Liposomal Formulation in Participants With Solid Tumor
Active, not recruiting · NCT03207672 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of E7389 Liposomal Formulation in Participants With Solid Tumor | Solid Tumor | Active, not recruiting | Phase 1 | 2026-08-27 | NCT03207672 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eisai Co., Ltd. | 15 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eisai Trial Site 1 | Chuo-ku | Japan | 2 |
| Eisai Trial Site 10 | Hidaka | Japan | 1 |
| Eisai Trial Site 11 | Kyoto | Japan | 1 |
| Eisai Trial Site 12 | Fukuoka | Japan | 1 |
| Eisai Trial Site 2 | Osaka | Japan | 1 |
| Eisai Trial Site 3 | Kashiwa | Japan | 1 |
| Eisai Trial Site 4 | Koto-ku | Japan | 1 |
| Eisai Trial Site 5 | Sapporo | Japan | 1 |
| Eisai Trial Site 6 | Yokohama | Japan | 1 |
| Eisai Trial Site 7 | Shinjuku-ku | Japan | 1 |
| Eisai Trial Site 8 | Nishinomiya | Japan | 1 |
| Eisai Trial Site 9 | Bunkyo-ku | Japan | 1 |